Showing Page 2 of 7
Priority Health Has Formulary Changes for Medicaid Members / Health Plan News
The MDHHS works with its health plan partners to create the Medicaid Health Plan Common Formulary, a list of drugs that all Medicaid health plans must cover.
Blue Cross Complete Neuropsychological Testing Guideline Summary / Health Plan News
Blue Cross Complete Neuropsychological Testing Guideline Summary.
Blue Cross Complete Contracts with OptumInsight Inc. for Payment Integrity Services / Health Plan News
Blue Cross Complete will contract with OptumInsight, Inc., to ensure claims are paid accurately.
Priority Health’s: Priority Actions for Providers / Health Plan News
Welcome to Priority Health’s biweekly PriorityActions for providers, where you’ll receive important information to help you work with Priority Health and care for their members.
Patients Who Suffer from Chronic Pain Often Need Advance Support / Health Plan News
Blue Cross Complete offers a range of services and benefits to aid in the treatment of patients suffering from chronic pain.
The American Diabetes Association (ADA) Standards of Care in Diabetes is updated and published annually.
Governor Whitmer Has Proclaimed That January 2024 Is Social Determinants of Health (SDOH) Month in Michigan. / OSP News
The Michigan Department of Health and Human Services (MDHHS) will bring together partners and communities across Michigan to observe Social Determinants of Health Month (SDOH).
Blue Cross Complete (BCC) of Michigan January/February 2024 Newsletter / Health Plan News
Blue Cross Complete (BCC) of Michigan January/February 2024 Newsletter.
Blue Cross Complete’s Important Guidelines to Submitting Claims / Health Plan News
Blue Cross Complete has important guidelines for providers filing claims.
Blue Cross Complete to Manage EviCore Prior Authorization Requests / Health Plan News
Blue Cross Complete will be the single point of contact for all new prior authorization requests, prior authorization requests for continuation of services, and retrospective authorization requests previously managed by eviCore healthcare.
Getting Back on Track After the Holidays / OSP News
The holiday season brings people together with gatherings and meals together. Getting back on track with health goals after the holidays can be challenging. Below are some tips to get started.
Blue Cross Complete (BCC) of Michigan December 2023 Complete Update / Health Plan News
Blue Cross Complete (BCC) of Michigan December 2023 Complete Update.
HAP Updates for December 2023 / Health Plan News
HAP Updates for December 2023 can be found in the HAP Provider Newsroom.
HAP CareSource Dual Medicare/Medicaid is Coming to Availity January 1 / Health Plan News
Beginning January 1, 2024, Availity will serve as HAP CareSource MI Health Link’s exclusive EDI gateway service for HAP CareSource MI Health Link members.
MDHHS to End Healthy Risk Assessment program / Health Plan News
The Michigan Department of Health and Human Services will retire the Healthy Michigan Plan Health Risk Assessment.
Updated Social Determinants of Health (SDoH) Resource Guides for Southeast Michigan / Health Plan News
New adult and pediatric SDoH resource guides for Southeast Michigan.
The Blues 2024 Products at a Glance Documents / Health Plan News
The Products at a Glance document is a general summary of BCN and BCBSM products and should not be used to determine a member’s benefits.
UPDATED: Correction to Blue Cross Complete's Prior Authorization Requirement Removed for Select Enteral Services / Health Plan News
Blue Cross Complete (BCC) issued a notice on November 27, 2023, that listed several enteral services as no longer requiring prior authorization. However, BCC have reversed this decision.
Blue Cross Complete's Prior Authorization Requirement Removed for Select Enteral Services / Health Plan News
Removal of the prior authorization and medical necessity review for these services is part of Blue Cross Complete’s continued dedication to supporting providers in our shared commitment to high quality health care for members.
The drug manufacturer, Novo Nordisk®, announced that it will discontinue it’s long-acting insulin Levemir in the United States.